These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M, Uchiyama H, Tamura R, Ida M, Yagi T, Yasuda K, Genma H, Hayakawa H, Chida K, Nakamura H. J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726 [Abstract] [Full Text] [Related]
5. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study. Ji SY, Zeng FQ, Guo Q, Tan GZ, Tang HF, Luo YJ, Tang ZQ, Han YF. Chin Med J (Engl); 2010 Mar 05; 123(5):517-22. PubMed ID: 20367973 [Abstract] [Full Text] [Related]
6. Opportunistic infections in polymyositis and dermatomyositis. Marie I, Hachulla E, Chérin P, Hellot MF, Herson S, Levesque H, Hatron PY. Arthritis Rheum; 2005 Apr 15; 53(2):155-65. PubMed ID: 15818648 [Abstract] [Full Text] [Related]
7. Interstitial lung disease in polymyositis and dermatomyositis. Marie I, Hachulla E, Chérin P, Dominique S, Hatron PY, Hellot MF, Devulder B, Herson S, Levesque H, Courtois H. Arthritis Rheum; 2002 Dec 15; 47(6):614-22. PubMed ID: 12522835 [Abstract] [Full Text] [Related]
8. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis. So MW, Koo BS, Kim YG, Lee CK, Yoo B. J Rheumatol; 2011 Nov 15; 38(11):2432-5. PubMed ID: 21844145 [Abstract] [Full Text] [Related]
10. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis]. Tong SQ, Shi XH, Su JM, Zhao Y, Zhang FC. Zhonghua Yi Xue Za Zhi; 2006 Mar 07; 86(9):624-7. PubMed ID: 16681909 [Abstract] [Full Text] [Related]
13. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study. Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T. PLoS One; 2015 Mar 07; 10(3):e0120313. PubMed ID: 25789468 [Abstract] [Full Text] [Related]
16. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Huang YL, Chen YJ, Lin MW, Wu CY, Liu PC, Chen TJ, Chen YC, Jih JS, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. Br J Dermatol; 2009 Oct 07; 161(4):854-60. PubMed ID: 19558555 [Abstract] [Full Text] [Related]
17. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study. Yang Z, Lin F, Qin B, Liang Y, Zhong R. J Rheumatol; 2015 Feb 07; 42(2):282-91. PubMed ID: 25448790 [Abstract] [Full Text] [Related]
19. [Prognosis of life in polymyositis/dermatomyositis]. Murabayashi K, Saito E, Okada S, Ogawa T, Kinoshita M. Ryumachi; 1991 Aug 07; 31(4):391-7. PubMed ID: 1948455 [Abstract] [Full Text] [Related]